PlexusDx is not affiliated with Mochi Health
Specifically, we offer compounded Tirzepatide (same active ingredient as Zepbound) and Semaglutide (same active ingredient as Ozempic and Wegovy)
How many treatments are recommended
$834.00 *NOT AVAILABLE to AL, ID, AK, HI This past June, the US Food and Drug Administration approved GLP-1, a glucagon-like peptide 1 receptor agonist, for chronic weight management, based on results from the four 68-week STEP (Treatment Effect in People with obesity) trials
The future of healthcare will always matter.But the future of public health depends just as much on the habits we normalize every day
Regarding respiratory outcomes, while most findings were not statistically significant, GLP-1 RAs were associated with benefits in specific clinical scenarios, such as reducing the risk of pneumonia and improving outcomes in individuals with COVID-19, possibly mediated by anti-inflammatory mechanisms